USD 95.78
(-1.06%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 9.89 Billion | 10.04 Billion | 10.93 Billion | 7.98 Billion | 7.28 Billion | 7.09 Billion |
Cost of Revenue | 5.57 Billion | 5.44 Billion | 4.7 Billion | 4.7 Billion | 4.37 Billion | 4.08 Billion |
Gross Profit | 4.31 Billion | 4.6 Billion | 6.23 Billion | 3.27 Billion | 2.91 Billion | 3.01 Billion |
Operating Expenses | 127.2 Million | 166.7 Million | 168.6 Million | 158.8 Million | 161.8 Million | 132.2 Million |
Selling, General and Administrative Expenses | 127.2 Million | 125 Million | 125.2 Million | 126.2 Million | 131.8 Million | 102.6 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 41.7 Million | 43.4 Million | 32.6 Million | 30 Million | -30.7 Million |
Cost and Expenses | 5.7 Billion | 5.61 Billion | 4.86 Billion | 4.86 Billion | 4.53 Billion | 4.21 Billion |
Operating Income | 4.19 Billion | 4.43 Billion | 6.06 Billion | 3.12 Billion | 2.75 Billion | 2.88 Billion |
Interest Expense | 326.7 Million | 340.1 Million | 357.1 Million | 366.6 Million | 340.7 Million | 277.1 Million |
Income Tax Expense | 1.51 Billion | 1.61 Billion | 2.29 Billion | 1.17 Billion | 945.3 Million | 1.05 Billion |
Earnings before Tax | 3.95 Billion | 4.26 Billion | 5.69 Billion | 2.74 Billion | 2.42 Billion | 2.58 Billion |
Net Income | 2.42 Billion | 2.63 Billion | 3.39 Billion | 1.57 Billion | 1.48 Billion | 1.54 Billion |
Earnings Per Share Basic | 3.09 | 3.41 | 4.39 | 2.03 | 1.92 | 2.00 |
Earnings Per Share Diluted | 3.09 | 3.41 | 4.39 | 2.03 | 1.92 | 2.00 |
Weighted Average Shares Outstanding | 785.51 Million | 773.1 Million | 773.1 Million | 773.1 Million | 773.1 Million | 773 Million |
Weighted Average Shares Outstanding (Diluted) | 785.51 Million | 773.1 Million | 773.1 Million | 773.1 Million | 773.1 Million | 773 Million |
Gross Margin | 0.44 | 0.46 | 0.57 | 0.41 | 0.40 | 0.42 |
EBIT Margin | 0.51 | 0.54 | 0.63 | 0.49 | 0.48 | 0.50 |
Profit Margin | 0.25 | 0.26 | 0.31 | 0.20 | 0.20 | 0.22 |
EBITDA | 5.02 Billion | 5.23 Billion | 6.85 Billion | 3.88 Billion | 3.53 Billion | 3.54 Billion |
Earnings Before Tax Margin | 0.42 | 0.44 | 0.55 | 0.39 | 0.38 | 0.41 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | -5.71 Billion | 3.11 Billion | 2.59 Billion | 9.89 Billion | 2.29 Billion | 2.5 Billion |
Cost of Revenue | 2.85 Billion | 1.47 Billion | 1.37 Billion | 5.57 Billion | 1.39 Billion | 1.38 Billion |
Gross Profit | -8.57 Billion | 1.64 Billion | 1.22 Billion | 4.31 Billion | 901.8 Million | 1.11 Billion |
Operating Expenses | 31.3 Million | 33.9 Million | 30.8 Million | 127.2 Million | 33.1 Million | 48.2 Million |
Selling, General and Administrative Expenses | 31.3 Million | 33.9 Million | 30.8 Million | - | 33.1 Million | 32.7 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 900 Thousand | -19.9 Million | 19 Million | 3.6 Million | -21.3 Million | 8.9 Million |
Cost and Expenses | 2.88 Billion | 1.51 Billion | 1.41 Billion | 5.7 Billion | 1.42 Billion | 1.43 Billion |
Operating Income | 1.45 Billion | 1.6 Billion | 1.18 Billion | 4.19 Billion | 868.7 Million | 1.06 Billion |
Interest Expense | -410.6 Million | 83.3 Million | 80.5 Million | 376.3 Million | 80.9 Million | 81.5 Million |
Income Tax Expense | -1 Billion | 578.8 Million | 423.4 Million | 1.51 Billion | 348.6 Million | 395.3 Million |
Earnings before Tax | 1.42 Billion | 1.53 Billion | 1.15 Billion | 3.95 Billion | 787.7 Million | 1.01 Billion |
Net Income | 2.42 Billion | 950.2 Million | 736 Million | 2.42 Billion | 445 Million | 619.5 Million |
Earnings Per Share Basic | 3.12 | 1.21 | 0.95 | - | 0.58 | 0.80 |
Earnings Per Share Diluted | 3.12 | 1.21 | 0.95 | - | 0.58 | 0.80 |
Weighted Average Shares Outstanding | 778 Million | 782.25 Million | 773.1 Million | 773.1 Million | 773.1 Million | 773.1 Million |
Weighted Average Shares Outstanding (Diluted) | 778 Million | 782.25 Million | 773.1 Million | 773.1 Million | 773.1 Million | 773.1 Million |
Gross Margin | 1.50 | 0.53 | 0.47 | 0.44 | 0.39 | 0.45 |
EBIT Margin | -0.74 | 0.58 | 0.54 | - | 0.47 | 0.52 |
Profit Margin | -0.42 | 0.30 | 0.28 | 0.25 | 0.19 | 0.25 |
EBITDA | 4.22 Billion | 1.81 Billion | 1.39 Billion | - | 1.07 Billion | 1.31 Billion |
Earnings Before Tax Margin | -0.25 | 0.52 | 0.46 | 0.42 | 0.38 | 0.43 |
HSIC
TSRUF
CRESW
MME
WOCKPHARMA
603390